Edition:
United States

American Renal Associates Holdings Inc (ARA.N)

ARA.N on New York Stock Exchange

17.73USD
19 Oct 2018
Change (% chg)

$-0.54 (-2.96%)
Prev Close
$18.27
Open
$18.23
Day's High
$18.42
Day's Low
$17.64
Volume
26,822
Avg. Vol
42,033
52-wk High
$24.02
52-wk Low
$9.91

Latest Key Developments (Source: Significant Developments)

American Renal Associates And Unitedhealthcare Reach Settlement
Monday, 9 Jul 2018 04:15pm EDT 

July 9 (Reuters) - American Renal Associates Holdings Inc ::AMERICAN RENAL ASSOCIATES AND UNITEDHEALTHCARE REACH SETTLEMENT.AMERICAN RENAL ASSOCIATES HOLDINGS INC - UNDER TERMS OF AGREEMENT, ARA WILL PAY $32 MILLION.AMERICAN RENAL ASSOCIATES - CO, UNITEDHEALTHCARE EXECUTED BINDING SETTLEMENT TERM SHEET; WILL BE NEGOTIATING TERMS OF DEFINITIVE SETTLEMENT BY AUG 1.AMERICAN RENAL ASSOCIATES HOLDINGS INC - UNDER TERMS OF AGREEMENT, ARA TO FOLLOW CERTAIN PROCEDURES AND SHARE INFORMATION WITH UNITEDHEALTHCARE.AMERICAN RENAL ASSOCIATES - IN CONJUNCTION WITH AGREEMENT, ARA & UNITEDHEALTHCARE TO ENTER 3-YEAR NETWORK AGREEMENT, EFFECTIVE AUGUST 1.AMERICAN RENAL ASSOCIATES HOLDINGS INC - UNITEDHEALTHCARE INTENDS TO SHARE FUNDS SECURED UNDER SETTLEMENT WITH ITS SELF-FUNDED CUSTOMERS.AMERICAN RENAL ASSOCIATES - SETTLEMENT AGREEMENT RELEASES ALL CLAIMS ASSERTED AGAINST ARA & OTHER NAMED DEFENDANTS IN FLORIDA & MASSACHUSETTS ACTIONS.AMERICAN RENAL ASSOCIATES - AGREEMENT ALSO RELEASES ALL CLAIMS ARISING FROM ACTIONS BROUGHT IN FLORIDA/MASSACHUSETTS ASSERTED AGAINST ARA.  Full Article

American Renal Associates & Its Unit Are Defendants In Lawsuit
Wednesday, 28 Mar 2018 09:09am EDT 

March 28 (Reuters) - American Renal Associates Holdings Inc ::AMERICAN RENAL ASSOCIATES - CO'S UNIT & ITS UNIT ARE DEFENDANTS IN A LAWSUIT INITIALLY FILED ON JULY 1, 2016 BY 3 AFFILIATES OF UNITEDHEALTH GROUP.AMERICAN RENAL ASSOCIATES SAYS ON MARCH 27, U.S. COURT ENTERED ORDER GRANTING THE MOTION TO DISMISS IN PART & DENYING THE MOTION IN PART - SEC FILING.AMERICAN RENAL ASSOCIATES - U.S. COURT ENTERED THE MARCH 27 ORDER REGARDING THE MOTION FILED UNDER A SECOND AMENDED COMPLAINT BY UNITEDHEALTH ON MARCH 13, 2017.  Full Article

American Renal Associates Holdings Qtrly EPS $0.05
Tuesday, 6 Mar 2018 04:01pm EST 

March 6 (Reuters) - American Renal Associates Holdings Inc ::AMERICAN RENAL ASSOCIATES HOLDINGS, INC. ANNOUNCES FOURTH QUARTER 2017 RESULTS.Q4 ADJUSTED EARNINGS PER SHARE $0.18.NET PATIENT SERVICE OPERATING REVENUES FOR Q4 OF 2017 WERE $194.4 MILLION, A DECREASE OF 2.4%.TOTAL DIALYSIS TREATMENTS FOR Q4 OF 2017 WERE 565,945, REPRESENTING AN INCREASE OF 6.7%.COMPANY EXPECTS 2018 ADJUSTED EBITDA-NCI TO BE IN A RANGE OF $110 MILLION AND $116 MILLION.QTRLY EARNINGS PER SHARE $0.05.  Full Article

American Renal Associates Settles Shareholder Class Action Litigation
Thursday, 1 Feb 2018 08:21am EST 

Feb 1 (Reuters) - American Renal Associates Holdings Inc ::AMERICAN RENAL ASSOCIATES HOLDINGS, INC. ANNOUNCES SETTLEMENT OF SHAREHOLDER CLASS ACTION LITIGATION.AMERICAN RENAL ASSOCIATES HOLDINGS INC - PROPOSED SETTLEMENT PROVIDES FOR A TOTAL SETTLEMENT PAYMENT OF $4.0 MILLION.  Full Article

American Renal Associates Holdings reports adj. EPS $0.19
Tuesday, 14 Nov 2017 04:05pm EST 

Nov 14 (Reuters) - American Renal Associates Holdings Inc :Announces third quarter 2017 results.Q3 adjusted earnings per share $0.19.Q3 earnings per share view $0.16 -- Thomson Reuters I/B/E/S.Qtrly ‍net patient service operating revenues decreased 2.7 pct to $187.7 million​.‍Reiterating its prior guidance for 2017 adjusted EBITDA less NCI to be in a range of $100 million and $106 million​.‍Company is reiterating its prior guidance for 2017 adjusted EBITDA less NCI to be in a range of $100 million and $106 million​.  Full Article

American Renal Associates reports Q2 adj earnings per share $0.16
Tuesday, 8 Aug 2017 04:15pm EDT 

Aug 9 (Reuters) - American Renal Associates Holdings Inc -:American Renal Associates Holdings Inc announces second quarter 2017 results.Q2 adjusted earnings per share $0.16.Q2 earnings per share view $0.12 -- Thomson Reuters I/B/E/S.American Renal Associates Holdings -reiterating its prior guidance for 2017 adjusted ebitda less nci to be in a range of $100 million and $106 million.  Full Article

American Renal Associates Holdings files for possible resale by selling stockholders of up to 19 million shares - SEC filing‍​
Tuesday, 18 Jul 2017 06:46am EDT 

July 18 (Reuters) - American Renal Associates Holdings Inc :American Renal Associates Holdings files for possible resale by selling stockholders of up to 19 million shares of common stock - SEC filing‍​.  Full Article

American Renal Associates Holdings Inc says units entered into credit agreement
Monday, 26 Jun 2017 06:22am EDT 

June 26 (Reuters) - American Renal Associates Holdings Inc :American Renal Associates Holdings Inc - on june 22, units entered into a credit agreement - SEC filing.American Renal Associates Holdings Inc - new credit agreement provides for $100 million senior secured revolving credit facility.American Renal Associates Holdings Inc - agreement also provides for $440 million senior secured term b loan facility.  Full Article

American Renal Associates Holdings announces Q1 loss per share $0.40
Tuesday, 9 May 2017 04:10pm EDT 

May 9 (Reuters) - American Renal Associates Holdings Inc :American Renal Associates Holdings, Inc. announces first quarter 2017 results.Q1 adjusted earnings per share $0.06.Q1 earnings per share view $0.10 -- Thomson Reuters I/B/E/S.Q1 loss per share $0.40.Patient service operating revenues for Q1 of 2017 were $177.0 million, an increase of 2.8%.  Full Article

American Renal Associates Holdings Q4 adjusted EPS $0.26
Tuesday, 7 Mar 2017 04:15pm EST 

American Renal Associates Holdings Inc : American Renal Associates Holdings, Inc. announces fourth quarter 2016 results . Q4 adjusted earnings per share $0.26 . Q4 loss per share $0.02 . Q4 earnings per share view $0.28 -- Thomson Reuters I/B/E/S . American Renal Associates Holdings Inc - qtrly net patient service operating revenues were $199.1 million, an increase of 14.3% versus Q4 2015 . Company expects 2017 adjusted EBITDA less NCI to be lower than in 2016 . American Renal - 2017 adjusted ebitda to be lower, due to impact from reductions from affordable care act-compliant individual marketplace plans .American Renal Associates Holdings Inc - co believes 2017 adjusted EBITDA less NCI could be impacted by headwinds like medicare rebasing.  Full Article